All News

An expert explains the different types of kidney cancer surgeries, and what patients can expect to experience after the procedure.

I’m giving cancer’s “battle language” an update and focusing my survivorship plan on emotional wellbeing and honesty.

Researchers developed an artificial intelligence algorithm to potentially improve the prediction of colon cancer recurrence, which may help patients receive the appropriate treatment.

A clinical trial recently kicked off, analyzing the combination of imetelstat plus Jakafi for the treatment of myelofibrosis, a type of rare blood cancer.

I recently was asked to speak at a banquet for my cancer center and saw that as a great opportunity to recognize those who cared for me.

Firefighters and recovery workers exposed to the aftermath of 9/11 in New York City had a higher occurrence of MGUS, a condition which may progress to myeloma, according to recent research.

I'm no longer the "helpless patient with cancer," though sometimes I need a reminder to keep myself in check.

Long-term follow-up shows that treatment with Empliciti plus pomalidomide and dexamethasone continues to significantly increase survival rates in patients with relapsed or refractory multiple myeloma, a persistent cancer affecting white blood cells that may be resistant to treatment.

Moreen is a tireless advocate for our patients, ensuring that all receive timely and compassionate care.

Many participants enrolled in the CRC-PREVENT trial are from communities often underrepresented in clinical trials due to gender, race and socioeconomic status, among other factors.

After being homebound for two years from the COVID-19 pandemic, I was eager to get out, though I did have many cancer/COVID-19 concerns.

The Food and Drug administration has approved Pemazyre for patients with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) with an FGFR1 rearrangement.

The phase 3 MAGNOLIA trial will assess whether abelacimab can prevent venous thromboembolism recurrence in patients with gastrointestinal or genitourinary cancers.

From the death of a football Hall of Famer and a golf champion to actress and former Nickelodeon star Jennette McCurdy discussing her mother’s breast cancer in her memoir, “I’m Glad My Mom Died,” here’s what’s happening in the cancer space this week.

Receiving a pancreatic cancer diagnosis has caused me to reexamine my spirituality, which led me to believe that my life is a line, rather than a single dot in time.

More patients with pretreated non-small cell lung cancer saw their disease disappear with abivertinib compared to Tagrisso.

Here's a step-by-step guide on how I drew the superhero that I wish existed to fight my wife's cancer.

Cervical cancer survivor Ginny Marable heard about a story of a fellow cervical cancer survivor, Tamika Felder, not being able to preserve her fertility. The story moved Marable so much that she and her husband donated their embryos to Felder.

In recent years, immunotherapy’s usage has expanded for the treatment of patients with kidney cancer.

The FDA approved Imbruvica for children over the age of 1 who are experiencing chronic GVHD that has already been treated by one or more prior therapy.

Radiotherapy with standard of care for the treatment of patients with low-burden metastatic prostate cancer had minimal effects on quality of life over a five-year follow-up period.

Among the many lessons I’ve learned since my diagnosis with cancer, there’s one in particular that I refer to daily. It’s a lesson learned from wearing a pair of odd-looking shoes.

Patients with stage 3 melanoma who had metastases larger than 0.3 millimeters had poorer survival outcomes and may benefit from adjuvant therapy, recent findings showed.

Patients with malignant pleural mesothelioma tended to have prolonged benefit when treated with Keytruda plus Lenvima in the PEMMELA clinical trial.

The Food and Drug Administration put a full clinical hold on a study of the novel drug FHD-286 in patients with acute myelogenous leukemia and myelodysplastic syndrome after study data showed an increase in a potentially fatal side effect.

When doctors told me that there was no more they could do for my stage 4 lung cancer, I refused to believe them, and wish other patients did the same.

From bald heads paired with lush eyebrows to the typical emaciated patient, there are certain tropes of how cancer is portrayed on TV that bother me, as they do not represent the experiences of everyone with the disease.